Fact Checked

SurvivorNet Fact Checking and Medical Review Standards:  

The SurvivorNet News Team creates high quality medical information that complies with our industry leading standards for factual accuracy and sourcing from leading experts at academic medical institutions. Every news article is thoroughly fact-checked by our physician collaborators. We vet each piece of work for factual integrity, impartiality, and clearly label any professional conflicts.

All SurvivorNet articles adhere to the following standards:

  1. All studies and research papers cited are from reputable academic medical institutions or peer-reviewed journals.
  2. When we use data, statistics, or quotes these references link to the original source.
  3. All content related to new treatments, drugs, procedures, and so on must clearly describe availability, side effects, treatment target (such as triple negative breast cancer)
  4. All medical information on SurvivorNet is sourced from respected medical professionals with verified medical credentials and links are provided to these sources.
  5. We strive to give the reader relevant background information and include, clearly-sourced contextual health information in all articles. Readers are clearly alerted to any conflicts of interest from a medical source or the authors of a cited study.
/ Updated January 25th, 2019

Antibody as Part of Initial Treatment For Multiple Myeloma?

NOW
PLAYING
A New Way to Deliver Daratumumab -- An Exciting Development in Multiple Myeloma
NOW
PLAYING
Adding Daratumumab to Front-line Therapy in Multiple Myeloma
NOW
PLAYING
The Benefit of Adding Daratumumab to Multiple Myeloma Drug Combinations
NOW
PLAYING
"An Important Step": FDA Approves New Combination Treatment For Newly Diagnosed Multiple Myeloma Patients
NOW
PLAYING
The Revolution in Multiple Myeloma Treatment
NOW
PLAYING
Starting Out on The Treatment Journey – What Lies Ahead?
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.